PNC Financial Services Group
INFI

PNC Financial Services Group’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

PNC Financial Services Group’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-480
Closed -$266 – 4863
2022
Q4 		$266 Hold
480
– – ﹤0.01% 4607
2022
Q3 		$1K Hold
480
– – ﹤0.01% 4375
2022
Q2 		$0 Hold
480
– – ﹤0.01% 4808
2022
Q1 		$1K Hold
480
– – ﹤0.01% 4433
2021
Q4 		$1K Hold
480
– – ﹤0.01% 4358
2021
Q3 		$2K Hold
480
– – ﹤0.01% 4160
2021
Q2 		$1K Hold
480
– – ﹤0.01% 4156
2021
Q1 		$2K Hold
480
– – ﹤0.01% 3987
2020
Q4 		$1K Buy
+480
New +$792 ﹤0.01% 3932
2016
Q3 		– Sell
-336
Closed – – 4340
2016
Q2 		$0 Sell
336
-13
-4% -$61 ﹤0.01% 4562
2016
Q1 		$2K Sell
349
-1,988
-85% -$12.2K ﹤0.01% 4235
2015
Q4 		$19K Buy
2,337
+2,000
+593% +$17.2K ﹤0.01% 3337
2015
Q3 		$3K Sell
337
-1,989
-86% -$18.3K ﹤0.01% 4185
2015
Q2 		$26K Buy
2,326
+149
+7% +$1.91K ﹤0.01% 3387
2015
Q1 		$30K Buy
2,177
+4
+0.2% +$61 ﹤0.01% 3311
2014
Q4 		$37K Buy
+2,173
New +$31.6K ﹤0.01% 2912

Other funds holding INFI

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PNC Financial Services Group's INFI Position: Q1 2023 in Review

PNC Financial Services Group sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q1 2023, closing a stake of 480 shares — an estimated $266 sold.

PNC Financial Services Group first reported a position in INFI in Q4 2014 and held it in 16 quarters. The position peaked at $37K in Q4 2014. 53 funds tracked by Wall St. Rank hold INFI as of Q1 2023.

  • PNC Financial Services Group reported no remaining Infinity Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
  • PNC Financial Services Group sold 480 Infinity Pharmaceuticals, Inc. shares in Q1 2023, an estimated $266.
  • PNC Financial Services Group first reported a position in Infinity Pharmaceuticals, Inc. in Q4 2014 and held it in 16 quarters.
  • PNC Financial Services Group's Infinity Pharmaceuticals, Inc. position peaked at $37K in Q4 2014.
  • 53 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q1 2023.

Based on PNC Financial Services Group's 13F filing for Q1 2023, filed 15 May 2023.